Ahead of the first Zantac lawsuit trials, slated to begin next year, investors sold off Sanofi, GlaxoSmithKline and Pfizer stocks, anticipating massive court losses and costs.
The first California Zantac bellwether trials have been pushed back to February 2023.
Makers of brand-name drugs want a federal judge to exclude expert witnesses for plaintiffs, seeking a summary judgment to have Zantac cancer risk lawsuits dismissed before they can make it…
A new report finds recalls of medications, medical devices, food and consumer goods have surged in the first three months of 2022.
A federal judge has scheduled hearings over Zantac cancer lawsuit Daubert motions for September.
Belviq global settlement discussions could lead to a resolution of all cancer lawsuits filed over the recalled weight loss drug, a federal judge says.
Pfizer is recalling five lots of Accupril, a hypertension drug, due to the risk of nitrosamine contamination and long-term cancer risk.
Pfizer is recalling several lots of Accuretic hypertension drugs due to the presence of potentially cancer-causing chemicals.
A Belviq colon cancer lawsuit will proceed, but without the plaintiffs ability to pursue punitive damages, an Ohio Magistrate Judge has ruled.
Two former district judges have been appointed as valsartan settlement special masters to help bring about a resolution to the litigation.